Herbert Oelschläger

1000 total citations
129 papers, 751 citations indexed

About

Herbert Oelschläger is a scholar working on Organic Chemistry, Spectroscopy and Molecular Biology. According to data from OpenAlex, Herbert Oelschläger has authored 129 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Organic Chemistry, 33 papers in Spectroscopy and 31 papers in Molecular Biology. Recurrent topics in Herbert Oelschläger's work include Analytical Chemistry and Chromatography (25 papers), Analytical Methods in Pharmaceuticals (13 papers) and Pharmacogenetics and Drug Metabolism (12 papers). Herbert Oelschläger is often cited by papers focused on Analytical Chemistry and Chromatography (25 papers), Analytical Methods in Pharmaceuticals (13 papers) and Pharmacogenetics and Drug Metabolism (12 papers). Herbert Oelschläger collaborates with scholars based in Germany, Czechia and France. Herbert Oelschläger's co-authors include J. Volke, Hermann Hoffmann, Ewa Kurek, Karl Kindler, Walter Vetter, Bernd Luckas, Wolfgang Schmidt, Andreas Seeling, D. J. Temple and E. Karge and has published in prestigious journals such as Electrochimica Acta, Marine Pollution Bulletin and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

Herbert Oelschläger

119 papers receiving 692 citations

Peers

Countries citing papers authored by Herbert Oelschläger

Since Specialization

Citations

This map shows the geographic impact of Herbert Oelschläger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Oelschläger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Oelschläger more than expected).

Fields of papers citing papers by Herbert Oelschläger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Oelschläger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Oelschläger. The network helps show where Herbert Oelschläger may publish in the future.

Co-authorship network of co-authors of Herbert Oelschläger

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert Oelschläger. A scholar is included among the top collaborators of Herbert Oelschläger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert Oelschläger. Herbert Oelschläger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma 2007 ·Journal of Cancer Research and Clinical Oncology ·Michael Hartmann, (unknown), Antoine Schneider, R. Kath, Oumar Camara, Herbert Oelschläger	3
2	Single and chronic administration of ciprofibrate or of ciprofibrate-glycinate in male Fischer 344 rats: Comparison of the effects on morphological and biochemical parameters in liver and blood 2005 ·European Journal of Drug Metabolism and Pharmacokinetics ·Amelie Lupp, E. Karge, (unknown), Thomas Deufel, Herbert Oelschläger, W Klinger	1
3	Investigations on the thermal behavior of omeprazole and other sulfoxides. 2005 ·PubMed ·(unknown), Heike Bunjes, Andreas Seeling, Herbert Oelschläger	6
4	Investigations of Interactions of Chlormezanone Racemate and Its Enantiomers on Human Keratinocytes and Human Leucoytes in vitro 2005 ·Skin Pharmacology and Physiology ·Uwe Wollina, U.‐C. Hipler, Andreas Seeling, Herbert Oelschläger	3
5	Fibrates and their newly synthesized glycinate or glycinate-methylester derivatives: Comparison of the interactions with liver cytochrome P450 dependent monooxygenase- and oxidase-functions in vitro 2003 ·Experimental and Toxicologic Pathology ·Amelie Lupp, E. Karge, (unknown), (unknown), Herbert Oelschläger, Christian Fleck	4
6	Interaction of chlormezanone enantiomers with rat liver microsomes 1999 ·European Journal of Drug Metabolism and Pharmacokinetics ·W Klinger, Herbert Oelschläger, (unknown), E. Karge, Andreas Seeling	1
7	Ciprofibrate — racemate and enantiomers: Effects of a four-week treatment on male inbred Fischer rats. A biochemical and morphological study 1998 ·Experimental and Toxicologic Pathology ·W Klinger, Amelie Lupp, E. Karge, Herbert Oelschläger, (unknown), (unknown), W Linss, Susan M. Lobel, Thomas Deufel, Michael Müller, Matthias Klinger, Wolfgang Kühnel	1
8	Chromatographic resolution of Ciprofibrate and interaction of the racemate and both enantiomers with rat liver microsomes in vitro 1998 ·Experimental and Toxicologic Pathology ·Herbert Oelschläger, (unknown), W Klinger, E. Karge, (unknown)	1
9	Zur Pharmakokinetik von Lipidsenkern, 10. Mitt.: Zweiter Beitrag zur Frage der Dehalogenierung des Lipidsenkers Ciprofibrat 1994 ·Archiv der Pharmazie ·Herbert Oelschläger, Karl‐Heinz Hellwich, (unknown)	2
10	Identification of drug glucuronides in human urine by RP-HPLC after derivatization 1994 ·Journal of Pharmaceutical and Biomedical Analysis ·Christopher Kohl, Herbert Oelschläger, (unknown)	5
11	Zur Pharmakokinetik von Lipidsenkern, 9.Mitt.: Zur Frage der biliären Ausscheidung des Lipidsenkers Ciprofibrat (1) (2‐[4‐(2,2‐Dichlorcyclopropyl)‐phenoxy]‐2‐methylpropionsäure) 1992 ·Archiv der Pharmazie ·Herbert Oelschläger, (unknown), D.K. Schroder, (unknown)	4
12	Analysis of Drugs by Polarography, XXXV: The Polarographic Behaviour of Cinolazepam. [1‐(2‐Cyanoethyl)‐7‐chloro‐3‐hydroxy‐5‐(2‐fluorophenyl)‐1,3‐dihydro‐2H‐1,4‐benzodiazepin‐2‐one] and Assay of its Tablets 1992 ·Archiv der Pharmazie ·Herbert Oelschläger, J. Volke, Fathalla Belal	4
13	Arzneimittelanalysen mittels polarographischer Methoden, 33. Mitt.: Elektroanalytische Untersuchungen an einem neuen Benzodiazepin: [6‐(2‐Chlorphenyl)‐2‐(4‐methyl‐1‐piperazinylmethylen) ‐8‐nitro‐2H‐imidazol[1,2‐a][1,4]benzodiazepin‐1(4H)‐on (VO) (Loprazolam, 1)] und Gehaltsbestimmung seiner Arzneiformen 1990 ·Archiv der Pharmazie ·Herbert Oelschläger, J. Volke, (unknown), (unknown)	4
14	Über das elektrochemische Verhalten (DCP, DPP) des Alprazolam (Tafil) und Gehaltsbestimmung seiner Arzneiformen 1987 ·Fresenius Journal of Analytical Chemistry ·Herbert Oelschläger, (unknown)	1
15	Synthese und Reaktivität des 3,5‐Dinitrobenzoesäureanhydrids 1984 ·Archiv der Pharmazie ·Herbert Oelschläger, (unknown)	1
16	[Polarographic determination of the hyperstic agent flurazepam in its commercial forms 20. Drug analyses using polarographic methods]. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Herbert Oelschläger, (unknown), (unknown)	8
17	Arzneimittelanalysen mittels polarographischer Methoden, 19. Mitt.: Bestimmung des Medazepams und seiner Hauptmetabolite durch Kathodenstrahl‐Polarographie 1976 ·Archiv der Pharmazie ·Herbert Oelschläger, (unknown)	6
18	The Metabolism of the Local Anaesthetic Fomocaine (1-Morpholino-3-[p-phenoxymethylpheny1]propane) in the Rat and Dog after Oral Application 1975 ·Xenobiotica ·Herbert Oelschläger, D. J. Temple, (unknown)	8
19	Polarographische Bestimmung des Phenacetins über sein o‐Nitroderivat. 1. Mitt.: Arzneimittelanalysen mittels Polarographie oder Oszillopolarographie 1963 ·Archiv der Pharmazie ·Herbert Oelschläger	10
20	Über die Spaltung der Kohlenstoff‐Sauerstoff‐Bindung bei der Hydrierung von N‐allylierten N‐[γ‐(4‐Phenoxymethylphenyl)‐propyl]‐aminen 1960 ·Archiv der Pharmazie ·Herbert Oelschläger	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact